Search for a trial

NABGEM study: nab-paclitaxel plus gemcitabine in patients with locally unresectable pancreatic cancer.

A disease control of 60% is expected and will be clinically relevant with a lower reference bound of 45%.

UGT1A1 genotype-guided dosing of irinotecan

To develop a dosing nomogram of irinotecan in patients homozygous polymorphic for UGT1A1*28 and/or UGT1A1*93 in order to reduce the incidence of severe irinotecan-associated toxicity, defined as febrile neutropenia in the first 2 cycles (amendment…

Reduceren van de4 kosten van de controle van patienten met niet-spier-invasief blaaskanker

1) Surveillance of patients with a urine test, followed by cystoscopy only when the urine test is positive, results in detection of a the same or a higher number of recurrences and is cost-effective and 2) urine diagnostics contribute to earlier…

How to overcome poor GP-CN communication by use of SBAR protocol

The use of SBAR by Community Nurses will improve their selfefficacy and empowerment.

Risk Communication about Alternative Health Promotion Strategies

1. Which factors influence electronic cigarette use?